A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma.,Blood Cancer Journal

当前位置： X-MOL 学术 › Blood Cancer J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma.
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2021-09-03 , DOI: 10.1038/s41408-021-00545-w
Karthik Ramasamy ₁ , Ajay Nooka ₂ , Hang Quach ₃ , Myo Htut ₄ , Rakesh Popat ₅ , Michaela Liedtke ₆ , Sascha A Tuchman ₇ , Jacob Laubach ₈ , Cristina Gasparetto ₉ , Asher Chanan-Khan ₁₀ , Mark Hertzberg ₁₁ , Mark deMario ₁₂ , Eveline Nueesch ₁₃ , Evelyne Chesne ₁₃ , Izolda Franjkovic ₁₄ , Katharina Lechner ₁₄ , Martin Kornacker ₁₃ , Hearn Jay Cho _{15,

16}

Affiliation

Department of Haematology, Oxford University Hospital, NHS Trust, Oxford, United Kingdom.
Winship Cancer Institute, Emory University, Atlanta, GA, USA.
University of Melbourne, St. Vincent's Hospital, Fitzroy, VIC, Australia.
City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
University College London Hospitals, NHS Foundation Trust, London, United Kingdom.
Stanford University Cancer Center, Stanford, CA, USA.
Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Newton, MA, USA.
Department of Medicine, Duke Univ. Medical Center, Durham, NC, USA.
Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA.
Department of Clinical Haematology, Prince of Wales Hospital, Sydney, NSW, Australia.
Roche Pharma Research and Early Development, New York, NY, USA.
Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland.
Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany.
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Multiple Myeloma Research Foundation, Norwalk, CT, USA.